Remove Arcturus Remove San Diego Remove Study Remove Venture Capital
article thumbnail

Arcturus Therapeutics Gets $220M More In Support For Vaccine Efforts

socalTECH

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds. READ MORE>>.

Arcturus 113